Alucent Medical Receives FDA Approval to Begin Clinical Trials of Novel Therapy for Vascular Disease
May 17, 2017
May 17, 2017 05:00 AM Mountain Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Alucent Medical, Inc. has announced that it has received U.S. Food and Drug Administration (FDA) approval to begin Phase 1 human clinical studies of Natural Vascular Scaffolding (NVS)™, its Read more…